Ihn, H., Kim, Y., Lim, S., Bae, J., Jung, J., Kim, Y., . . . Park, E. (2021). PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo. Int J Mol Sci.
Citación estilo ChicagoIhn, Hye-Jung, et al. "PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis Through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo." Int J Mol Sci 2021.
Cita MLAIhn, Hye-Jung, et al. "PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis Through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo." Int J Mol Sci 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.